Inexia Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

Inexia General Information

Description

Developer of intranasal orexin receptor agonists and positive modulators designed to treat narcolepsy. The company's modulators leverage optinose's unique exhalation delivery system for the nose to brain delivery, enabling patients to restore orexin levels in the brain and improve symptoms.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 24 Chiswell Street
  • London EC1Y 4YX
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 24 Chiswell Street
  • London EC1Y 4YX
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inexia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 16-Feb-2021 Completed Startup
1. Early Stage VC 04-Feb-2019 Completed Startup
To view Inexia’s complete valuation and funding history, request access »

Inexia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Inexia’s complete cap table history, request access »

Inexia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inexia Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medicxi Ventures (UK) Venture Capital Minority
To view Inexia’s complete investors history, request access »

Inexia FAQs

  • When was Inexia founded?

    Inexia was founded in 2018.

  • Where is Inexia headquartered?

    Inexia is headquartered in London, United Kingdom.

  • What is the size of Inexia?

    Inexia has 3 total employees.

  • What industry is Inexia in?

    Inexia’s primary industry is Drug Discovery.

  • Is Inexia a private or public company?

    Inexia is a Private company.

  • What is Inexia’s current revenue?

    The current revenue for Inexia is .

  • How much funding has Inexia raised over time?

    Inexia has raised $4.57M.

  • Who are Inexia’s investors?

    Medicxi Ventures (UK) has invested in Inexia.

  • When was Inexia acquired?

    Inexia was acquired on 16-Feb-2021.

  • Who acquired Inexia?

    Inexia was acquired by Centessa Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process